Skip to main content
Journal ArticleOPEN ACCESS

Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report

  • Colaci M
  • Sebastiani M
  • Sandri G
  • et al.
Case Reports in Infectious Diseases (2011) 2011 1-3
DOI: 10.1155/2011/530568
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

TNF-alpha blockers represent one of the most important therapeutic strategies for rheumatoid arthritis, but their use has raised the question about their safety profile, particularly in respect to viral infections/reactivations. We describe the case of a patient who developed a symptomatic EBV reactivation 11 days after the first infusion of infliximab.

Cite

CITATION STYLE

APA

Colaci, M., Sebastiani, M., Sandri, G., Meacci, M., & Ferri, C. (2011). Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report. Case Reports in Infectious Diseases, 2011, 1–3. https://doi.org/10.1155/2011/530568

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free